AS
Amit Subhashchandra Khandelwal
About Amit Subhashchandra Khandelwal
Amit Subhashchandra Khandelwal has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Pharmagenics Healthcare Llp and Kp Green Engineering Limited. Formerly with 1 company. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Kp Green Engineering Limited
L40100GJ2001PLC039763
|
Director | 06 Dec 2023 | 2001 | Active |
K.P. Energy Limited
L40100GJ2010PLC059169
|
Whole-Time Director | 02 Feb 2024 | 2010 | Active |
Kpi Green Energy Limited
L40102GJ2008PLC083302
|
Director | 04 Dec 2023 | 2008 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Pharmagenics Healthcare Llp
AAY-2578
|
Designated Partner | 20 Aug 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Subhashchandra Khandelwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Subhashchandra Khandelwal
Amit Subhashchandra Khandelwal has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Pharmagenics Healthcare Llp and Kp Green Engineering Limited. Formerly with 1 company. Engaged in Healthcare, General Business. Contributes to corporate operations.
Amit Subhashchandra Khandelwal is associated with 3 companies as Designated Partner and Director.
Amit Subhashchandra Khandelwal has expertise in Healthcare, General Business.
Amit Subhashchandra Khandelwal has 5 years in corporate governance.